ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 100 filers reported holding ACLARIS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.65 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $165,000 | -18.7% | 11,799 | +0.3% | 0.01% | -17.6% |
| Q1 2022 | $203,000 | -33.9% | 11,766 | -44.4% | 0.02% | -37.0% |
| Q4 2021 | $307,000 | -37.6% | 21,143 | -22.6% | 0.03% | -54.2% |
| Q3 2021 | $492,000 | +37.4% | 27,315 | +34.1% | 0.06% | +7.3% |
| Q2 2021 | $358,000 | +8.8% | 20,366 | +56.1% | 0.06% | -23.6% |
| Q1 2021 | $329,000 | – | 13,043 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,954,904 | $49,264,000 | 43.26% |
| COMMODORE CAPITAL LP | 1,028,084 | $25,908,000 | 10.32% |
| Foresite Capital Management IV, LLC | 3,399,034 | $85,656,000 | 10.26% |
| VR Adviser, LLC | 3,720,582 | $93,759,000 | 10.17% |
| Parkman Healthcare Partners LLC | 1,709,136 | $43,070,000 | 10.00% |
| Foresite Capital Management V, LLC | 1,258,243 | $31,708,000 | 9.32% |
| Stenahm Asset Managment Ltd | 283,500 | $7,144,000 | 5.04% |
| Samsara BioCapital, LLC | 1,022,612 | $25,770,000 | 4.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 336,737 | $8,486,000 | 4.63% |
| Ghost Tree Capital, LLC | 600,000 | $15,120,000 | 3.55% |